Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial.
Saved in:
| Title: | Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial. |
|---|---|
| Authors: | Jahn N; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Jahn E; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Saadati M; Saadati Solutions, Ladenburg, Germany., Bullinger L; Department of Hematology, Oncology and Tumor Immunology, Charité University, Berlin, Germany., Larson RA; Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA., Ottone T; Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.; Santa Lucia Foundation, Neuro-Oncohematology, I.R.C.C.S., Rome, Italy., Amadori S; Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy., Prior TW; Case Western Reserve University, Cleveland, OH, USA., Brandwein JM; Department of Medicine, University of Alberta, Edmonton, AB, Canada., Appelbaum FR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Medeiros BC; Division of Hematology, Stanford Comprehensive Cancer Center, Stanford University, Stanford, CA, USA., Tallman MS; Division of Hematologic Malignancies, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ehninger G; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Pallaud C; Novartis Pharmaceuticals, Basel, Switzerland., Gathmann I; Novartis Pharmaceuticals, Basel, Switzerland., Krzykalla J; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany., Benner A; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany., Bloomfield CD; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Thiede C; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany., Stone RM; Department of Medical Oncology, Dana-Farber/Partners CancerCare, Boston, MA, USA., Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany. konstanze.doehner@uniklinik-ulm.de. |
| Source: | Leukemia [Leukemia] 2022 Sep; Vol. 36 (9), pp. 2218-2227. Date of Electronic Publication: 2022 Aug 03. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35922444 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jahn+N%22">Jahn N</searchLink>; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Jahn+E%22">Jahn E</searchLink>; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Saadati+M%22">Saadati M</searchLink>; Saadati Solutions, Ladenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Bullinger+L%22">Bullinger L</searchLink>; Department of Hematology, Oncology and Tumor Immunology, Charité University, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Larson+RA%22">Larson RA</searchLink>; Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Ottone+T%22">Ottone T</searchLink>; Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.; Santa Lucia Foundation, Neuro-Oncohematology, I.R.C.C.S., Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Amadori+S%22">Amadori S</searchLink>; Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Prior+TW%22">Prior TW</searchLink>; Case Western Reserve University, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Brandwein+JM%22">Brandwein JM</searchLink>; Department of Medicine, University of Alberta, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Appelbaum+FR%22">Appelbaum FR</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Medeiros+BC%22">Medeiros BC</searchLink>; Division of Hematology, Stanford Comprehensive Cancer Center, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tallman+MS%22">Tallman MS</searchLink>; Division of Hematologic Malignancies, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ehninger+G%22">Ehninger G</searchLink>; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Heuser+M%22">Heuser M</searchLink>; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Ganser+A%22">Ganser A</searchLink>; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Pallaud+C%22">Pallaud C</searchLink>; Novartis Pharmaceuticals, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gathmann+I%22">Gathmann I</searchLink>; Novartis Pharmaceuticals, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Krzykalla+J%22">Krzykalla J</searchLink>; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Benner+A%22">Benner A</searchLink>; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Bloomfield+CD%22">Bloomfield CD</searchLink>; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Thiede+C%22">Thiede C</searchLink>; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Stone+RM%22">Stone RM</searchLink>; Department of Medical Oncology, Dana-Farber/Partners CancerCare, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Döhner+H%22">Döhner H</searchLink>; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Döhner+K%22">Döhner K</searchLink>; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany. konstanze.doehner@uniklinik-ulm.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2022 Sep; Vol. 36 (9), pp. 2218-2227. <i>Date of Electronic Publication: </i>2022 Aug 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35922444 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41375-022-01650-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2218 Titles: – TitleFull: Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jahn N – PersonEntity: Name: NameFull: Jahn E – PersonEntity: Name: NameFull: Saadati M – PersonEntity: Name: NameFull: Bullinger L – PersonEntity: Name: NameFull: Larson RA – PersonEntity: Name: NameFull: Ottone T – PersonEntity: Name: NameFull: Amadori S – PersonEntity: Name: NameFull: Prior TW – PersonEntity: Name: NameFull: Brandwein JM – PersonEntity: Name: NameFull: Appelbaum FR – PersonEntity: Name: NameFull: Medeiros BC – PersonEntity: Name: NameFull: Tallman MS – PersonEntity: Name: NameFull: Ehninger G – PersonEntity: Name: NameFull: Heuser M – PersonEntity: Name: NameFull: Ganser A – PersonEntity: Name: NameFull: Pallaud C – PersonEntity: Name: NameFull: Gathmann I – PersonEntity: Name: NameFull: Krzykalla J – PersonEntity: Name: NameFull: Benner A – PersonEntity: Name: NameFull: Bloomfield CD – PersonEntity: Name: NameFull: Thiede C – PersonEntity: Name: NameFull: Stone RM – PersonEntity: Name: NameFull: Döhner H – PersonEntity: Name: NameFull: Döhner K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2022 Sep Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1476-5551 Numbering: – Type: volume Value: 36 – Type: issue Value: 9 Titles: – TitleFull: Leukemia Type: main |
| ResultId | 1 |